POSTPARTUM ATYPICAL HEMOLYTIC UREMIC SYNDROME. CLINICAL OBSERVATIONS AND HISTOLOGICAL FEATURES
https://doi.org/10.24884/1561-6274-2017-2-98-106
Abstract
Described two clinical observations of atypical hemolytic-uremic syndrome (AHUS) in patients in the second and third trimesters of pregnancy. Presented cases characterize severe course of AHUS that despite timely diagnostics, early initiation of therapy had an adverse clinical outcome. For the first time in Russian literature described the morphological changes of renal tissue by results of histological studies of autopsy material obtained from patients with AHUS.
About the Authors
L. I. Rudenko
Rostov state medical University
Russian Federation
Russian Federation
Nephrologist, Rudenko L., PhD
Department of nephrology.
344022 Rostov-on-Don, the lane Nakhichevansky, 29
M. M. Batiushin
Rostov state medical University
Russian Federation
Russian Federation
Professor Mikhail М. Batiushin MD, PhD, DMedSci.
Department of Internal Medicine № 2.
344022, Rostov-on-Don, trans. Nakhichevan, 29.
A. E. Matcionis
Rostov region Pathoanatomical Bureau
Russian Federation
Russian Federation
Matsionis Alexander E., Doctor of Medical Science
344015, Rostov-on-Don, st. Blagodatnaya, 170А.
M. Yu. Kaminskii
Rostov state medical University
Russian Federation
Russian Federation
Kaminskij Mihail Jur’evich, PhD
Department of nephrology, Department of anesthesiology and reanimatology with the course of toxicology.
344022, Rostov-on-Don, the lane Nakhichevansky, 29.
G. L. Reznikova
Rostov region Pathoanatomical Bureau
Russian Federation
Russian Federation
Reznikova Galina Leonidovna, PhD
344015, Rostov-on-Don, Blagodatnaja str. 170A.
Yu. M. Makarenko
Rostov region Pathoanatomical Bureau
Russian Federation
Russian Federation
Makarenko Jurij Markovich, PhD
344015, Rostov-on-Don, Blagodatnaja str. 170A.
References
1. Antonio FS, Roman J, Wyble A et al. Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome. AJP 2016;6(1):125–128
2. Батюшин ММ. Атипичный гемолитико-уремический синдром при беременности и hellp-синдром. Вопросы дифференциальной диагностики. Клин нефрол 2014;(2-3):46–52 [Batiushin MM. Atypical hemolytic-uremic syndrome in pregnancy and hellp syndrome. Issues of differential diagnosis. Klinicheskaja nefrologija. 2014;(2-3):46–52]
3. Fakhouri F, Roumenina L, Provot F et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 2010;21(5):859–867
4. Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol 2011;26(1):41–57
5. Campistol JM, Arias M, Ariceta G, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 2013;33(1):27–45
6. Nester CM, Thomas CP. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated? Hematology Am Soc Hematol Educ Program 2012(1):617-25
7. Макарова ТП, Давлетбаева ГР, Поладова ЛВ и др. Опыт приминения экулизумаба у ребенка с атипичным гемолитикоуремическим синдромом. Нефрология 2014;18(3):84–88 [Makarova TP, Davletbaeva GR, Poladova LV i dr. Experience the use of eculizumab in a child with atypical hemolytic-uremic syndrome. Nefrologija. 2014;18(3):84–88]
8. Козловская НЛ, Коротчаева ЮВ, Боброва ЛА, Шилов ЕМ. Акушерский атипичный гемолитико-уремическоий синдром: первый российский опыт диагностики и лечения. Нефрология 2016;20(2):68–80. [Kozlovskaja NL, Korotchaeva JuV, Bobrova LA, Shilov EM. Obstetric atypical hemolytic-urameshi syndrome: the first Russian experience of diagnosis and treatment. Nefrologija. 2016;20(2):68–80]
9. Коротчаева ЮВ, Козловская НЛ, Бондаренко ТВ, Веселова ГА. Особенности течения и лечения «акушерского» атипичного гемолитико-уремического синдрома. Нефрология 2015;19(2):76–81. [Korotchaeva JuV, Kozlovskaja NL, Bondarenko TV, Veselova GA. Peculiarities of course and treatment of «obstetric» atypical hemolytic-uremic syndrome. Nefrologija. 2015;19(2):76–81]
10. Tsai HM. A Mechanistic Approach to the Diagnosis and Management of Atypical Hemolytic Uremic Syndrome Transfusion. Med Reviews 2014;28:187–97
11. Caprioli J, Noris M, Brioschi S. et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006;108(4):1267–1279
12. Michael M, Elliott EJ, Ridley GF. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 2009;1:CD003595
13. Kappler S, Ronan-Bentle S, Graham A. Thrombotic Microangiopathies (TTP,HUS, HELLP). Emerg Med Clin N Am 2014; 32:649–671
14. Legendre CM, Licht C, Muus P et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013;368(23):2169–2181
15. Mackaness C, Fleszler F. Eculizumab in the successful treatment of postpartum atypical hemolytic uremic syndrome – a case report. NKF 2014 Spring Clinical Meetings Abstracts. Am J Kidney Dis 2014;63(5):75
Review
For citations:
Rudenko L.I., Batiushin M.M., Matcionis A.E., Kaminskii M.Yu., Reznikova G.L., Makarenko Yu.M. POSTPARTUM ATYPICAL HEMOLYTIC UREMIC SYNDROME. CLINICAL OBSERVATIONS AND HISTOLOGICAL FEATURES. Nephrology (Saint-Petersburg). 2017;21(2):98-106. (In Russ.) https://doi.org/10.24884/1561-6274-2017-2-98-106
Views:
4876
Email this article 